Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type I diabetic patients on intensified treatment: A randomized study

Diabetes Care

Volumn 23, Issue 9, 2000, Pages 1232-1235

  Hanaire Broutin, H ^a   Melki, V ^a   Bessieres Lacombe, S ^a   Tauber, J P ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 0033857856     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.9.1232     Document Type: Article

References (21)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: A one centre experience
3. Clinical use of the insulin infusion pump in 100 patients with type I diabetes
4. Evaluation of insulin pump treatment under routine conditions
5. Reduction of severe hypoglycemic events in type I (insulin-dependent) diabetic patients using continuous subcutaneous insulin infusion
6. Reduction in severe hypoglycemia with long-term subcutaneous insulin infusion in type I diabetes
7. Improvement of HbA(1c) and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps
8. Insulin lispro in CSII: Results of double-blind crossover study
9. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial: German Humalog-CSII Study Group
10. A crossover comparison of continuous insulin infusion and conventional injection treatment of type I diabetes
11. Implementation of treatment protocols in the diabetes control and complications trial
12. Insulin analogues and their potential in the management of diabetes mellitus
13. Strategies toward improved control during insulin lispro therapy in IDDM
14. Improvement of blood glucose control in type 1 diabetic patients treated with lispro and multiple NPH injections
15. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime
16. Hypoglycemia in the diabetes control and complications trial
17. Continuous subcutaneous insulin infusion: A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes
18. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes
19. Variation in absorption of NPH insulin due to intramuscular injection
20. Pharmacokinetics of continuous subcutaneous insulin infusion
21. Within patient variability in postprandial glucose excursion with lispro insulin analog compared with regular insulin